NDC 49281-645 – Fluzone Trivalent Northern Hemisphere

Influenza A Virus A/switzerland/6849/2025 Ivr-278 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A Virus A/michigan/105/2025 San-049a (h3n2)… · Injection, Suspension · Intramuscular

Vaccine

Product NDC49281-645

Product details

Brand name
Fluzone Trivalent Northern Hemisphere
Generic name
INFLUENZA A VIRUS A/Switzerland/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)
Labeler
Sanofi Vaccines US Inc.
Dosage form
Injection, Suspension
Route
Intramuscular
Marketing category
BLA · BLA103914
Marketed since
July 2, 2025
Marketing end
June 30, 2027

Active ingredients

Package NDC codes (1)

Package NDCDescriptionSince
49281-645-151 VIAL, MULTI-DOSE in 1 PACKAGE (49281-645-15) / 5 mL in 1 VIAL, MULTI-DOSE (49281-645-78)Jul 2, 2025

Other Fluzone Trivalent Northern Hemisphere products